![]() Hemostemix Hemostemix is a biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. | ||
Founding Date | Founding Date 2006 | Founding Date 1996 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Calgary, CA HQ | |
Employees | Employees N/A | Employees 290 |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £178.8m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods £68.2m (FY, 2024) |
Gross profit | Gross profit $1.6m (FY, 2025) | Gross profit £110.6m (FY, 2024) |
Net income | Net income ($4.7m) (FY, 2025) | Net income (£10.7m) (FY, 2024) |

Alliance is an international pharmaceutical company.
View company